Daily Stock List
Longhai Steel Inc. (LGHS)
We are reporting on Longhai Steel Inc. (LGHS), here at the QualityStocks Daily Newsletter.
Longhai Steel Inc. Inc. is a producer of high quality steel wire products in the People's Republic of China. Downstream manufacturers process the Company's wire into screws, nails, and wire mesh used to reinforce concrete and for fencing. The delivery of all of the Company's sales is in China, with 80 percent going to customers in Hebei. Longhai manufactures high quality steel wire products in diameters from 5.5 to 18 millimeters in two wire production plants. Longhai Steel lists on the OTC Bulletin Board. The Company has their headquarters in Xingtai City, Hebei Province, China.
Longhai Steel's newly opened second production line also produces higher quality steel wire for specialized applications. These include steel wire rope, steel strand, steel belted radial tires, and steel welding rod. Once fully ramped, the Company's new production line will increase overall capacity by approximately 60 percent. The new line also has the capability to produce alloy steel, cold forging steel and welding rods. This new, higher margin product will allow Longhai Steel to address demand in markets in addition to construction and infrastructure.
Longhai Steel has an annual capacity of 1.5 million metric tons. Sales for the Company in 2010 were $480.0 million. Net income was $12.0 and total assets were $88.8 million at year-end for 2010. The Company's rolling and drawing facilities are among the most advanced in the world. Longhai has also acquired land adjacent to the two existing plants for the future addition of a third production facility.
In January, Longhai Steel announced record Fourth Quarter 2011 output and sales volume of steel wire. With additional capacity starting to come on line from the Company's newly opened second production facility, Fourth Quarter 2011 steel wire output was 293,862 Metric Tons. This is up 23 percent from 238,912 Metric Tons in the same period of 2010. Fourth Quarter 2011 steel wire sales volume was also a record at 335,229 Metric Tons. This is up 30 percent from 257,871 Metric Tons in the same period of 2010.
Longhai Steel Inc. (LGHS) closed Friday's trading session at $0.90, even with yesterday’s close, on 9,465 volume with 9 trades. The average volume for the last 60 days is 6,247. The 52-week low/high is $0.15/$11.00.
Dejour Energy Inc. Ltd. (DEJ)
StockHotTips, CRWEFinance, CRWEWallStreet, CRWEPicks, BestOtc, PennyOmega, DrStockPick, Wall Street Resources, and Stock Fortune Teller reported recently on Dejour Energy Inc. Ltd. (DEJ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Dejour Energy Inc. Ltd. is an independent oil and natural gas exploration and production company. They are operating projects in North America's Piceance Basin (107,000 net acres) and Peace River Arch regions (15,000 net acres). Dejour Energy has offices in Denver, Colorado, Calgary, Alberta, and Vancouver, British Columbia.
The Company's most significant oil and gas plays are in the U.S. Rocky Mountains. Here, their acreage position contains multiple projects in the Piceance, Uinta, and Paradox Basins in Eastern Utah and Western Colorado. Dejour has high graded four key projects in the Piceance Basin of western Colorado on acreage representing approximately 25 percent of their property holdings in the area. This basin is over 100 miles long and has an average width of more than 60 miles, encompassing an area of over 7,100 square miles. It contains reserves of coal, natural gas, and oil shale.
This month, Dejour Energy announced that the aB-1 oil well at their 75 percent owned Woodrush project in the Peace River Arch, Northeast British Columbia, has been successfully completed and tied into production at a current oil production rate of approximately 50 BOPD. The expectation is that the new well's flow rate will ramp up considerably as the reservoir continues to pressurize with the ongoing water injection program.
This week, Dejour Energy announced the receipt of a 2012 Reserve Evaluation for their South Rangely project (Piceance - Uinta Basins
Colorado/Utah) from Gustavson & Associates LLC of Boulder, Colorado. As previously reported the results of a vertical test and subsequent fracture stimulation confirmed a trapped hydrocarbon presence in commercial quantities and opened up Dejour's remaining South Rangely acreage to lower risk exploration down structure from this gas/NGL accumulation.
Dejour Energy and their partners will concentrate on the potential for an oil leg that is usually found down dip from similar NGL-laden gas accumulations in the Mancos "C" in this area. An action plan is undergoing establishment to unitize relevant acreage associated with this leasehold operated by Dejour (56 percent average Working Interest), establish production at the earliest possible date, and begin development of the adjacent five PUD locations.
Dejour Energy Inc. Ltd. (DEJ) closed Friday's session at $0.50, up 12.36%, on 5,235,830 volume with 4,613 trades. The average volume for the last 60 days is 1,733,074. The 52-week low/high is $0.21/$0.60.
China Pharma Holdings, Inc. (CPHI)
Greenbackers, PennyOmega, China Vesting, and Wall Street Resources reported earlier on China Pharma Holdings, Inc. (CPHI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
China Pharma Holdings, Inc. principally engages in the development, manufacture, packaging, marketing and distribution of generic and branded pharmaceutical products for a broad array of high incidence and high mortality conditions in The People's Republic of China (PRC). China Pharma's primary focus for their therapeutics includes CNS, cardiovascular, cerebrovascular, wound recovery, digestive disease, and infectious diseases. The Company conducts all of their operations in the PRC. China Pharma Holdings has their corporate headquarters in Haikou, Hainan, PRC.
The Company has an 8,000-square-meter manufacturing facility in the PRC. They have eight different production lines. They have the capability to manufacture pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. More than 90 percent of their pharmaceutical products sell on a prescription basis and have approval for at least one or more therapeutic indications by the Chinese State Food and Drug Administration (SFDA) based upon demonstrated safety and efficacy.
At September 30, 2011, China Pharma manufactured 20 pharmaceutical products for a wide variety of diseases and medical indications, each of which may be classified into one of three general categories. One is a basic generic drug, which is a common drug in the PRC marketplace for which there is a very large market. The second is a "super" or "first to market" generic drug, which is a generic Western drug that is new to the PRC marketplace.
The third is a modern Traditional Chinese Medicine, which usually is a non-synthetic, plant-based medicinal compound of the type that has been widely used in the PRC for thousands of years. To these the Company applies modern production techniques to produce a pharmaceutical product in different formulations, such as tablets, capsules or powders.
China Pharma markets and sells their products through 16 sales offices covering all major cities and provinces in the PRC. To comply with applicable Chinese law relating to sales of prescription drugs to certain hospitals and clinics, the Company also uses a distribution system consisting of approximately 1,250 independent regional distributors.
China Pharma Holdings, Inc. (CPHI) closed Friday's trading session at $0.72, up 0.01%, on 8,740 volume with 30 trades. The average volume for the last 60 days is 78,065. The 52-week low/high is $0.62/$3.10.
Polar Star Mining Corp. (PSR.TO)
We are highlighting Polar Star Mining Corp. (PSR.TO), here at the QualityStocks Daily Newsletter.
Polar Star Mining Corp. is an emerging exploration company that lists on the Toronto Stock Exchange. The Company focuses on building value in Chile through discovery and development. Their strategy is to use the cash flow from their Chepica mine (primarily gold) to fund, in part, the exploration program at their flagship Montezuma property and to advance their large portfolio of other world class projects in Chile through joint ventures. Polar Star Mining has their corporate headquarters in Toronto, Ontario.
The Company's flagship property, Montezuma, covers 40 kilometers of the West Fault and the crosscutting Esperanza Fault system. It is between Codelco's Radomiro Tomic - Chuquicamata - Ministro Hales (formerly known as Mansa Mina) group of copper-molybdenum porphyry deposits, and Antofagasta PLC's El Tesoro - Esperanza - Polo Sur group of copper-gold porphyry deposits. Polar Star believes that their 100 percent owned Montezuma property has the potential to host a major porphyry Cu+/-Mo+/-Au deposit.
Polar Star's Chépica property consists of a group of five adjoining exploitation (mining) concessions totaling 1,390 hectares, a producing gold-silver-copper mine, an associated sulfide flotation plant and related infrastructure. The Company holds an option to purchase agreement. With it, they can purchase 100 percent of the Chépica property, as well as associated mining and processing assets.
The Company has their Los Azules property. It is 800 kilometers north of Santiago, covers the historic Los Azules high-grade oxide copper-gold mining district and is readily accessible by paved and good gravel road from the city of Copiapo sixty kilometers to the west. The property covers a series of at least six breccias containing copper, uranium and molybdenum mineralization.
The property consists of 12 exploitation concessions totaling 2,577 hectares owned by Minera Celeste and 6 exploitation concessions totaling 997 hectares owned by third parties. Polar Star (via their wholly owned subsidiary Minera Celeste Chile Ltda.) holds 100 percent title to 12 exploration concessions totaling 2,600 hectares.
Polar Star Mining Corp. (PSR.TO) closed today's trading session at $0.41, down 7.87%, on 13,705 volume. The 52-week low/high is $0.36/$1.20.
CTD Holdings Inc. (CTDH)
Wall Street Resources reported recently on CTD Holdings Inc. (CTDH), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Alachua, Florida, CTD Holdings Inc.'s primary business is the development and marketing of cyclodextrins and related products. They develop cyclodextrins based applications for a broad spectrum of industries. These include food, pharmaceutical, nutraceutical, R&D and environmental remediation. Experienced chemistry and manufacturing veterans lead the Company.
Cyclodextrin Technologies Development, Inc. (CTD), organized as a Florida corporation on August 9, 1990 with operations beginning July 1992. In May of 1994, the Company became a fully reporting public company listed on the OTC BB under the symbol CTDI. In 2000, they altered their corporate structure to a holding company with subsidiary companies. CTD Holdings originally formed to market and sell Cyclodextrins and related products to the food, pharmaceutical, and other industries. Additionally, they provided consulting services related to Cyclodextrin Technology. CTD Holdings (CTDH), as a holding company, will acquire, create, and invest in companies that will develop, market, and/or sell products containing Cyclodextrins.
Cyclodextrins are donut shaped circles of glucose (sugar) molecules that bring together oil and water and have potential applications anywhere oil and water must be used together. Stabilization of food flavors and fragrances is the largest current global market for Cyclodextrin applications. CTD and others have developed Cyclodextrin-based applications in stabilization of flavors for food products; elimination of undesirable tastes and odors; preparation of antifungal complexes for foods and toiletries; stabilization of fragrances and dyes; reduction of foaming in foods; cosmetics and toiletries; and the improvement of quality, stability and storability of foods.
The Company has the largest catalogue of cyclodextrins in the world. They have earned the reputation as the provider of choice for many prestigious institutions and companies. One of CTD's core competencies is their proprietary manufacturing process managed and operated by the Company's wholly owned NSP subsidiary. This allows CTD to develop commercial scale high-grade cyclodextrin based products.
An integral part of CTD's overall strategy is to organize their subsidiaries around a specific cyclodextrin based solution. This allows each unit to address the specific changes and opportunities within their specific market better.
CTD Holdings Inc. (CTDH) closed today's trading session at $0.16, down 1.79%, on 31,864 volume with 8 trades. The average volume for the last 60 days is 16,284. The 52-week low/high is $0.03/$0.20.
International Isotopes Inc. (INIS)
SmallCapVoice reported earlier on International Isotopes Inc. (INIS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. In addition, they provide a broad selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications. Furthermore, they provide a host of analytical, measurement, recycling, and processing services on a contract basis to clients. International Isotopes has their headquarters in Idaho Falls, Idaho.
The Company's core business consists of six reportable segments. These include Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services, and Transportation. International Isotopes is in the licensing and design phase of their planned environmentally friendly, green technology, uranium de-conversion and fluorine extraction processing facility located near Hobbs, New Mexico. The Company believes this new commercial facility will provide an excellent commercial opportunity. They hold patents that give them exclusive rights for the Fluorine Extraction Process (FEP), a process that produces high value, high purity fluoride gasses in conjunction with uranium de-conversion.
The Company has developed a unique process to convert depleted uranium tails (by-product produced from the enrichment of uranium) to ultra high purity, high value industrial fluoride products. Fluoride products are a key raw material for microelectronics, fiber optic cable, thin film photovoltaics (solar cells) and many other manufacturing processes.
In November 2011, International Isotopes announced that they completed an agreement in principle with Idaho State University to develop jointly, processes for the production of Copper-67. Copper-67 has shown exceptional potential in the treatment of non-Hodgkin’s Lymphoma as well as bladder, colorectal, and ovarian cancers. However, it is a difficult isotope to produce and has not been consistently made available in the United States.
Last month, International Isotopes announced that the Nuclear Regulatory Commission (NRC) started the public notification and comment period on the draft EIS for the Company's planned depleted uranium de-conversion facility. As a part of the public comment period process, the NRC planned a public meeting in Hobbs, New Mexico on February 2, 2012. In addition to that public meeting, comments on the project and the draft EIS will be taken until February 27, 2012.
International Isotopes Inc. (INIS) closed Friday at $0.65, even with yesterday’s close. The average volume for the last 60 days is 1,842. The 52-week low/high is $0.15/$1.01.
Imperial Industries Inc. (IPII)
StockGuru reported previously on Imperial Industries Inc. (IPII), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Imperial Industries, Inc., through their subsidiaries, Premix-Marbletite Manufacturing Co. and Just-Rite Supply, Inc., is a manufacturer and marketer of branded products. These are distinguished by design and/or function for use in finishing exterior and interior walls for residential and commercial buildings. Founded in 1968, the Company is working to become the premier manufacturer and distributor of selected building products. Imperial Industries has their headquarters in Pompano Beach, Florida. The Company's shares trade on the OTC Bulletin Board.
The Company engages in the manufacturing and distribution of building materials to building materials dealers and others located primarily in Florida, Mississippi, Georgia, and Alabama and to a lesser extent, other states in the Southeastern part of the U.S., as well as foreign countries. They presently have distribution outlets through which they market certain of their manufactured products and other purchased products directly to developers, builders, contractors, and sub-contractors.
Products manufactured by Imperial Industries include stucco products, plaster products, roof tile mortar, adhesive products and pool finish products. Stucco products undergo application as a finishing coat to exterior surfaces and to swimming pools. Roof tile mortar is used to affix cement roof tiles to the roof. Plaster customarily is used to finish interiors of structures. Furthermore, the manufactured products are used for the finish coatings of in-ground swimming pools and as mortars for the attachment of cement roof tiles. Products distributed by the Company include gypsum, roofing and insulation products, as well as products manufactured by Imperial Industries.
Developers, general contractors and sub-contractors in the construction or renovation of residential, multi-family and commercial buildings and swimming pools use the Company's products. Established in the mid 1950's with two manufacturing plants in Florida, the Company's Premix-Marbletite Manufacturing subsidiary is the oldest manufacturer of stucco, plaster, and pool products in the state. Imperial Industries distributes products via their wholly owned subsidiary, Just-Rite Supply, which commenced operations January 1, 2000.
Imperial Industries Inc. (IPII) closed today's trading session at $0.65, even with yesterday’s close. The average volume for the last 60 days is 1,842. The 52-week low/high is $0.15/$1.01.
Fire River Gold Corp. (FAU.V)
Stockhouse, Agoracom, Vantage Wire, and Streetwise Reports reported previously on Fire River Gold Corp. (FAU.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Fire River Gold Corp. is Alaska's newest gold producer, with a projected 50,000 ounces per year of gold to undergo production on their wholly owned Nixon Fork Gold Mine located in the resource rich Tintina Gold Belt. Operations commenced in July of 2011. The plan is to ramp up to full production by summer 2012. This year-round mine program is producing concentrate and doré bars. Fire River Gold lists on the TSX Venture Exchange. The Company has their headquarters in Vancouver, British Columbia.
The Nixon Fork Mine is a past producing mine with a high-grade production history, and a low capital requirement due to pre-existing infrastructure. Mystery Creek Resources operates the Nixon Fork Mine. Mystery Creek is a wholly owned subsidiary of Fire River Gold. In addition to the mine, the property has an approximately 200 tonnes per day processing plant, surface and underground mobile equipment fleets, an 85 person fully equipped camp, 2 company owned drills, a self-contained power plant, water and septic systems, and a 1,280 meters long landing strip.
Mystery Creek has a renewable lease to explore and mine the ore bodies at Nixon Fork. Currently the mine life is approximately four years. Fire River Gold plans on extending it considerably beyond that period by replenishing what is mined on a yearly basis. Concerning Marketing Contracts, the doré produced from gravity separation and leaching consists of gold (60 percent), silver (30 percent), and impurities (10 percent). This contract has been secured with Johnson Matthey Inc. of Salt Lake City, Utah.
A three-year contract has been secured with Glencore International Ltd. for the sale of the copper concentrate produced at the Nixon Fork Gold Mine. The gold rich copper concentrate is to have moderate copper content that has varied from 10 percent to 25 percent historically.
Earlier this month, Fire River Gold and Mystery Creek Resources announced they have promoted Mr. Timothy G. Smith to Vice President and Chief Operating Officer (COO). Mr. Smith previously served as V.P. Operations this past year at Fire River Gold's Nixon Fork Mine.
Fire River Gold Corp. (FAU.V) closed Friday's trading session at $0.22, up 2.33%, on 163,500 volume. The 52-week low/high is $0.31/$0.58.
TiVUS, Inc. (TIVU)
The QualityStocks Daily Newsletter would like to spotlight TiVUS, Inc. (TIVU). Today, TiVUS, Inc. closed trading at $0.0003, up 50.00%, on 8,488,028 volume with 12 trades. The stock’s average daily volume over the past 60-day daily average volume is 22,787,919 with a 52-week low/high of $0.0001/$0.06.
TiVUS, Inc. (TIVU) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.
The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.
By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.
The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer
TiVUS, Inc. Company Blog
TiVUS, Inc. News:
TiVUS' Ad-Insertion Attracts Diverse Range of Advertisers
TiVUS' First Ad-Insertion Revenues Begin - Hotel TV advertising embraced by local merchants
TiVUS Commences Live Hotel TV Ad-Insertions
Beacon Enterprise Solutions Group, Inc. (BEAC)
The QualityStocks Daily Newsletter would like to spotlight Beacon Enterprise Solutions Group, Inc. (BEAC). Today, Beacon Enterprise Solutions Group, Inc. closed trading at $0.28, even for the day, on 15,614 volume with 5 trades. The stock’s average daily volume over the past 60-days is 60,984 with a 52-week low/high of $0.14/$0.60.
Beacon Enterprise Solutions Group, Inc. (BEAC) specializes in designing, implementing and managing high performance Information Technology Systems ("ITS") infrastructure solutions. Offering national, multi-national and global, turnkey ITS infrastructure solutions, the company is capable of delivery professional services to Fortune 1000 and large multi-site firms as they increasingly single source and outsource to reduce costs while optimizing critical planning, design, program, project and construction management and managed services.
Leveraging standardization, rapid mobilization and a just-in-time professional services approach, Beacon Enterprise Solutions serves as a single source for national, multi-national and global enterprise clients, including special practices focused on data centers, campuses, smart buildings, outside plant, wireless systems and other technology-based applications and projects. Clients are provided with consistent and predictable results anywhere in the world. The company's solutions allow clients to focus on their core businesses without the distraction of having employees spend valuable time on services that Beacon can provide on any continent, in any country using any language.
Headquartered in Louisville, Kentucky, with regional headquarters in Cincinnati, Ohio, Dublin, Ireland, and Prague, Czech Republic, in addition to personnel located throughout the United States and Europe, Beacon Enterprise Solutions services a diverse range of clients. For more than 30 years, the company has enabled businesses in a variety of vertical markets to dramatically reduce costs, enable global standardization, manage day-to-day technology systems moves, adds and changes, and take on major projects – all under a single national, multi-national or global agreement.
Beacon Enterprise Solutions has carefully assembled a seasoned management team and operating strategy to maximize organic growth and new business development across multiple vertical markets. More than 4,000 companies, from small businesses to Fortune 50 firms, have chosen the company's solutions. Disclaimer
Beacon Enterprise Solutions Group, Inc. Blog
Beacon Enterprise Solutions Group, Inc. News:
Beacon Enterprise Solutions Highlights New Product Offering for Fortune 1000 Clients
Beacon Enterprise Solutions Reports 36% Increase in Blended Project Funnel
Beacon Enterprise Solutions Hires Industry Sales Veteran
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.01, even for the day, on 602,050 volume with 5 trades. The stock’s average daily volume over the past 60-day daily average volume is 262,551 with a 52-week low/high of $0.0001/$0.0205.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings wholly-owned subsidiary Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Consorteum Holdings Completes Acquisition of Tarsin Inc.
Consorteum Holdings, Inc. Announces Lead Spokesman for the First Nations MasterCard Program
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.27, down 2.00%, on 3,480 volume with 5 trades. The stock’s average daily volume over the past 60-day daily average volume is 272 with a 52-week low/high of $1.20/$1.55.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Introduces New Management Team
GlobalWise Completes Acquisition of Intellinetics
eVero Announces a Strategic Partnership with Intellinetics
SANUWAVE Health, an emerging regenerative medicine company, today announced it has signed a two-year exclusive distribution agreement with CAN-med Healthcare of Canada, in which CAN-med will distribute SANUWAVE’s Pulsed Acoustic Cellular Expression (PACE®) technology for acute and chronic wound healing.
CAN-med distributes a wide range of medical offerings, including wound care and trauma products complementary of SANUWAVE’s dermaPACE.
“CAN-med Healthcare is a welcome addition to our growing distribution network for PACE technology, and they have the distinct honor of being the first PACE distributor in North America,” Christopher M. Cashman, president and CEO of SANUWAVE, stated in the press release. “dermaPACE is approved in Canada to treat a wide range of acute and chronic wounds. CAN-med Healthcare’s initial focus will be on the treatment of diabetic foot ulcers, leveraging positive data from our recently completed pivotal clinical trial investigating dermaPACE to treat these debilitating and costly ulcers.
“This collaboration is exciting news for both organizations, and we are equally committed to the hard work ahead of us to reach our ultimate goal of establishing dermaPACE as a first-line wound healing technology with established reimbursement throughout Canada.”
Stephen McDonald, CAN-med’s vice president and general manager, noted the beneficial impact the agreement has on his company and the Canadian healthcare market.
“dermaPACE technology is a great fit for us, as it builds upon our legacy of bringing new, leading edge products to the Canadian market. As a company, we’re always looking for exclusive partnerships that involve innovative, clinically validated and differentiated technology that can improve patient outcomes and overall delivery of care. We believe we’ve met these objectives with SANUWAVE,” McDonald stated.
Jim Ritcey, director of sales and marketing for CAN-med, echoed McDonald’s sentiment.
“It is the mandate of every health department in Canada to improve care to all Canadians, while staying within the confines of increasingly tighter budgets,” Ritcey stated. “We believe that dermaPACE, with its proven safety and efficacy, combined with its potential to reduce costs associated with chronic wound care, could truly be a ‘game changer’ in the battle against chronic wounds.”
Access Pharmaceuticals Inc., a biopharm company focused on the development of treatments in the areas of oncology, diabetes, and RNAi, today announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., has received regulatory approval from the State Food and Drug Administration (SFDA) to market MuGard in China.
China’s regulatory agency approved MuGard to treat cancer patients afflicted with oral mucositis a debilitating side effect of many anticancer treatments. The approval provides Access the opportunity to tap into an expansive market with a largely unmet medical need. Access will soon begin manufacturing MuGard in the United States to meet demand created by Jian An Ltd., Rhei’s sales and marketing partner in China.
“Receiving final marketing approval from the SFDA of China is a transformative milestone for our global MuGard program. China represents a key target market with its large and increasingly affluent population and its desire for improved oncology care,” Jeffrey B. Davis, president and CEO of Access stated in the press release. “With the approval process now complete, we look forward to moving as quickly as we can to complete manufacturing so Rhei and Jian An can launch MuGard through their well-established sales and marketing infrastructure in China.”
“China is one of the fastest growing oncology markets and cancer supportive care has been improving throughout recent years,” said Sven De Backer, CEO of Rhei. “Rhei and Jian An are proud to bring MuGard to patients and physicians as we believe it is a critical and valuable product that addresses a significant unmet need for a large and growing patient population.”
Access and Rhei last year signed a supply agreement for MuGard, which ensured manufacturing capacity of up to a minimum of $30 million of product in the licensed territories. Access also approved a sub-license agreement between Rhei and Jian designed to leverage Jian An’s sales, marketing, and regulatory infrastructure for the launch of MuGard in China and Taiwan.
Today, TechPrecision, widely known as a global leader in large-scale, precision component machining/fabrication via its wholly-owned subsidiaries Ranor, Inc., and Wuxi Critical Mechanical Components Co., Ltd., reported that Wuxi obtained ISO 9001:2008-compliant Quality Management System operator status for the fabrication, welding, and machining of precision components/equipment.
CEO of TPCS, James Molinaro, spoke of the meteoric rise of the company’s Wuxi subsidiary, which has become a “first-class global, and now certified, manufacturing operation” in just its first year since inception. Molinaro underscored how obtaining the key ISO certification on the first audit demonstrates that the reputation for excellence established by the company in large scale, precision manufacturing is well deserved.
Molinaro pointed to the China management team and personnel as being fundamental to the success achieved, hailing the dedicated and expedient work carried out by all levels of Wuxi staff as the push for ISO certification was made. This rousing victory perfectly characterizes the way TPCS has striven to exceed customer expectations and the ISO certification will serve as a reflection of the continued emphasis by the company on organic improvement.
A host of thriving global market sectors ranging from cleantech and alternative energy to nuclear, aerospace, defense, commercial maritime and industrial applications demand metal components and systems manufactured to within exacting standards. TPCS has built a reputation delivering critical components and continues driving towards the central goal of becoming a dominant provider of end-to-end, customized, fully integrated “turn-key” solutions in the fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing spaces.
The ISO 9000 (International Organization for Standardization) family of standards is an internationally recognized benchmarking system used to ensure operator adherence to rule sets defined by accreditation/certification bodies and allows an independent auditing process to certify conformance to formalized business processes. This certification allows for public statement that a company is “ISO 9001 certified/registered” and is a hallmark of reliability that was born in the heart of the manufacturing industry and has now grown to encompass a broad spectrum of organizations to validate standards adherence.
With a massive volume of experience operating in and doing business with various consumers of large-scale, critical components/systems, TPCS guides its subsidiaries through some of the most technically complex and challenging solutions demanded today.
For more information on TechPrecision Corp. please visit www.TechPrecision.com
Located in Addison, Texas, ULURU is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products through the utilization of its NanoFlex Aggregate technology and OraDisc transmucosal delivery system. Yesterday, ULURU took a major step towards prominence with the announcement they have received approval from the Australian Register of Therapeutic Goods Certificate to market Altrazeal in Australia.
ULURU President and CEO Kerry P. Gray stated, “This is another important milestone in the worldwide commercialization of Altrazeal®. Strategically this is an important market as the world’s largest wound research program is currently being conducted at the Wound Management Innovation Cooperation Research Centre in Australia. This centre’s focus is the development of clinically and cost effective treatment regimens for the management of chronic wounds. Gaining the support of this influential group could have significant global implications for the marketing of Altrazeal®. It is anticipated that the initial Altrazeal® orders for Australia will occur in the next thirty days. Also, marketing approval in New Zealand is anticipated to occur in the next thirty days.”
Gray further added, “The Australian state government’s strategic initiatives in wound care are focused on cost effective clinical endpoints and patient health and wellbeing. The pharmaco-economic benefits offered by Altrazeal could enable rapid market penetration in the Australian market.”
The timing of this approval is beneficial as a major Australian wound care meeting, the Australian Wound Management Association Conference, will be held in Sydney, Australia, on March 18-21, 2012. It is anticipated that over 1,000 delegates from Australia and New Zealand will be attending this conference. The conference will enable pre-marketing launch activities to be conducted and provide maximum exposure for Altrazeal to some of the most important wound treatment healthcare professionals from both countries.
Currently, ULURU is trading in the $0.52 range. To learn more about this press release or the company as a whole, visit their corporate website at www.uluruinc.com
Today's Top 3
The QualityStocks Public Company Sponsor News